Vaccine candidates for Ebola, other filoviruses show promise
UH researchers have demonstrated the efficacy in monkeys of multiple vaccine candidates targeting three filoviruses causing life-threatening infections to humans.
UH researcher’s team helps develop vaccine for COVID-19
Axel Lehrer and his lab colleagues are collaborating on developing a potential vaccine for the novel COVID-19 disease.
UH and African country collaborate on infectious disease efforts
The University of Hawaiʻi is working with the University of Liberia and Liberia’s government to improve global response to the next deadly infectious disease outbreak.
Ebola vaccine developed by UH can withstand high heat
Developed by UH Mānoa scientist Axel Lehrer, the vaccine remains viable in extreme heat conditions for several months, which is especially important where the disease outbreaks so far have begun in rural, spread-out areas of hot, dry West Africa.
Nearly $6.3M grant to expand promising Ebola vaccine research awarded to UH researcher
Axel Lehrer will test whether the Ebola vaccine formula he has developed will protect against two additional viruses in the same family.
UH expands vaccine research through NIH grant to minority students
Liana Medina received a grant of nearly $112,000 to work with a potential vaccine for viruses related to Ebola.
Potential new Ebola vaccine has heat-stable formulation
JABSOM's Axel Lehrer shares preliminary test results for a promising Ebola vaccine being developed to retain effectiveness without refrigeration.
Using math to predict Ebola
Through mathematical modeling, Yong and colleagues found that actions taken to halt the spread of the deadly virus may in fact increase transmission.
UH researcher’s book addresses, analyzes Ebola epidemic
Felix Ikuomola recounts real-life experiences while analyzing influences in spread of Ebola.
Heat stable Ebola vaccine goal of UH‘s newest partner
Soligenix joins JABSOM ebola vaccine development project to develop a heat stable Ebola vaccine.
